Sorafenib as first line treatment for advanced liver cancer-are expiries
Title
Sorafenib as first line treatment for advanced liver cancer-are expiries
Identifier
/unibl/sci/idNaucniRad:25642
Type
See all items with this valueConference Paper
Date
Bibliographic Citation
Z. Gojković, S. Jungić, I. Rakita, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, S. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer-are expiries, This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista), 2012
presented at
14th World Congres of Gastrointestinal Cancer
Is Part Of
See all items with this valueThis article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista)
list of authors
Position: 7136 (36 views)